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We present here a case of success kidney transplantation from a deceased donor who showed a serum creatinine 
level of 5.5 mg/dl. A 52-year-old Asian female with blood type O was determined to be brain death after a 
compressive craniectomy. Her post-operative course was fatal. She had experienced acute renal failure with oliguria, 
and these conditions had persisted for 3 days, and the serum creatinine level was elevated up to 5.5 mg/dl. 
The random urine creatinine, sodium and osmolarity levels were 17.6 mg/dl, 116 mmol/L and 346 mOsmol/L, 
respectively. However, the ultrasonographic and pathologic findings did not show any chronic structural abno-
rmality in the kidneys. Two female patients with blood type O were transplanted with these donor kidneys. Both 
recipients experienced 2∼3 days of delayed graft function, but the graft function was fully recovered at 4∼5 
day after transplantation. Both recipients were discharged with full-functioning grafts (1.1 and 0.9 mg/dl of serum 
creatinine, respectively). This shows that a deceased donor with reversible kidney damage, and even one showing 
a high serum creatinine level, can be acceptable for transplantation if the absence of chronic renal damage is 
confirmed by pathologic study. (J Korean Surg Soc 2008;75:430-433)
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INTRODUCTION
  In order to increase donor pools, transplantation using 
marginal donors or extended criteria donors (ECDs) has 
sometimes been accepted. Elderly donor, history of 
hypertension, brain death by cerebrovascular accident, and 
high serum creatinine (more than 1.5 mg/dl) were inclu-
sion criteria of ECDs for kidney transplantation.(1) The 
negative effects of donors with high serum creatinine level 
on delayed graft function (DGF) and graft survival is well 
documented.(2) However, the elevation of serum creatinine 
level does not directly indicate irreversible damage of a 
donor kidney.(3) Reversible kidney damage, such as toxic 
or ischemic acute renal failure, often occurs in brain dead 
patients. A few experiences using reversibly-damaged kid-
neys from deceased donors have been reported.(4)
  Here, we present a case of successful kidney trans-
plantation from a deceased donor with ischemic acute 
tubular necrosis, who showed a serum creatinine level of 
5.5 mg/dl. 
CASE REPORT
  The patient was a 52-year-old Asian female with blood 
type O. The past medical history of the patient did not 
include malignancy or diabetes, but the patient did have 
a 10-year history of hypertension, which was controlled 
with anti-hypertensive medication. The patient fell into full 
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Fig. 1. Daily change of urine output and serum creatinine level of
the deceased donor prior to organ donation.
Fig. 2. Histopathologic findings of the kidney from the deceased 
donor (H&E stain, ×100). 
coma suddenly, and was diagnosed with an acute subdural 
hematoma. In spite of decompressive craniectomy and 
hematoma evacuation being performed, the brain damage 
was irreversible. Brain death was diagnosed at 4 days after 
the operation by the Hospital Committee for Brain Death, 
and organ donation was approved.
  The pre-craniectomy serum creatinine level was 0.9 mg/ 
dl and urine protein was negative. Hypotensive episode and 
diabetes inspidus-induced diuresis were persistent for 2 
days after the operation. At 3 days after the operation, the 
serum creatinine level reached 4.7 mg/dl, and the daily 
urine output was decreased to less than 1,000 ml. The 
systolic blood pressure was maintained by using 8μg/ 
kg/min of dopamine and 0.1μg/kg/min norepinephrine. 
The blood urea nitrogen (BUN) and creatinine levels were 
39.9 and 5.2 mg/dl, respectively, and were maintained at 
40.9 and 5.5 mg/dl until organ donation at 5 days after 
the operation (Fig. 1). Random urine creatinine, sodium, 
and osmolarity levels were 17.6 mg/dl, 116 mmol/L, and 
346 mOsmol/L, respectively. Therefore, the BUN/creati-
nine ratio was 8.04, fractional excretion of sodium was 
21.1%, and the urine/plasma creatinine ratio was 3.2. All 
laboratory findings suggested intrinsic renal disease. 
Ultrasonographic evaluation did not show anatomic struc-
tural abnormality in either kidney. We inferred that the 
renal disease was ischemic acute tubular necrosis (ATN). 
We decided to use the donor kidneys if there were no 
pathologic findings on the renal biopsy. 
  Two stage 5 chronic kidney disease (CKD) patients with-
out diabetes were enrolled as recipient candidates. One 
candidate was a 29-year-old female who had been on 
hemodialysis for 77 months, and the other candidate was 
a 44-year-old female who had been on peritoneal dialysis 
for 57 months. Both recipient candidates were blood type 
O and 3 Ag-mismatch with the donor, and both candidates 
were eligible for primary transplant and had a low body 
mass index (BMI) (16.5 and 20.0 kg/m2, respectively). 
Informed consent for acceptance of an extended criteria 
donor kidney was obtained from recipient candidates. 
  At 5 days after the operation, multivisceral organ reco-
very was performed in the normal manner. Cold perfusion 
was performed using histidine-tryptophan-ketoglutarate 
(HTK) solution. Grossly, both kidneys showed a normal 
appearance and consistency. Kidney biopsy by true-cut 
needle was performed. The frozen biopsy reading was 
reported as no histologic abnormality (Fig. 2). Permanent 
section revealed rare granular casts. Kidney transplan-
tations for each recipient was simultaneously performed in 
the normal manner. The first recipient was given the left 
kidney (kidney weight=275 g) with 5 hours of cold ischemic 
time (CIT), and the second recipient was given the right 
kidney (kidney weight=292 g) with 6 hours of CIT.
  Induction immunosuppression, composed of polyclonal 
anti-thymocyte antibody and steroid, was performed in 
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both recipients. Infusion of anti-thymocyte antibody was 
maintained for 10 days after transplantation, followed by 
the administration of cyclosporine (CsA) and mycopheno-
late mofetil as maintenance immunosuppressive regimens. 
Methylprednisolone was used as an induction steroid and 
tapped to prednisolone (10 mg per day) as a maintenance 
dose. 
  The first recipient showed post-transplant oliguria for 2 
days after transplantation. Renal function was fully reco-
vered at 4 days after transplantation (daily urine out ＞ 
2,000 ml). The first recipient was discharged at 21 days 
after transplantation without complications or acute rejec-
tion. The BUN and creatinine levels at discharge were 18.5 
and 1.1 mg/dl, respectively. The second recipient, who was 
older than the first recipient, suffered from post-transplant 
oliguria for 3 days, and recovered at 5 days after trans-
plantation. Without complications, the second recipient 
was also discharged with a well-functioning graft (31.2 mg/ 
dl of BUN and 0.9 mg/dl of serum creatinine level) at 25 
days after transplantation. 
DISCUSSION
  The shortage of organs available for transplantation is 
a worldwide problem. For countries in which the occur-
rence of deceased donors is extremely rare, such as Re-
public of Korea and Japan, maximal utilization of deceased 
donor organs is necessary. Because the blood type O 
patient restrictively receives organs from donors with blood 
type O, the chance of allocation to a blood type O patient 
is relatively lower than that for potential recipients with 
other blood types. Therefore, unusual use of blood type O 
donors for blood type O transplant candidates is necessary. 
This is the main motivation of using organs from a donor 
that showed an extremely high level of serum creatinine 
(5.5 mg/dl) in this case. 
  The quality of a donor kidney is a key parameter in 
decision about the acceptability of an organ. Many quan-
titative or qualitative criteria were developed for the 
assessment of organ quality.(5,6) The donor age was found 
to be the strongest parameter affecting post-transplant graft 
survival and function.(7) In the United Network for Organ 
Sharing (UNOS), an elderly donor greater than 60 years 
of age is regard as ECD.(1) History of hypertension, 
cerebrovascular accident-related brain death, and high 
serum creatinine in fifties aged donor were additional 
criteria for ECD.(1) The high serum creatinine level was 
an independent risk factor affecting post-transplant graft 
survival and function. Particularly, the final serum creati-
nine level measured just before organ recovery was a strong 
predictor of graft failure and delayed graft function 
(DGF).(8) However, extended criteria took less into con-
sideration about the reversibility of renal damage. The 
natural course of acute renal damage is different from that 
of chronic renal damage. The majority (more than 90%) 
of acute renal damage is caused by ischemic or toxic ATN, 
and such renal damage is reversible and may recover within 
3 weeks. Therefore, the use of a donor kidney affected by 
reversible kidney disease is reasonable. 
  The permanent damage to the kidney can be confirmed 
by pathologic findings. Glomerulosclerosis, tubular atrophy, 
and interstitial fibrosis are typical pathologic findings. 
These morphological changes and a quantified score were 
found to be linearly correlated with post-transplant graft 
survival rates.(9) Because the detection rate of positive 
pre-transplant pathologic findings was very small, the rou-
tine application of pre-transplant biopsy was not recom-
mended.(9) However, elevation of serum creatinine and 
oliguria are major hallmarks of permanent renal damage. 
Therefore, a pre-transplant kidney biopsy should be per-
formed to assess a potential donor who has an extremely 
high serum creatinine level. In this case, both a radiological 
imaging study and a pre-transplant renal biopsy were 
performed. The pre-transplant pathologic confirmation of 
the absence of irreversible kidney disease was determined 
to be essential for kidney transplantation using an ECD 
kidney. 
  It is generally accepted that an ECD kidney has a 
suboptimal nephron mass. Therefore, ECD kidneys are al-
located to patients who have low metabolic or immuno-
logic demand, such as patients who are elderly (more than 
40 years old), have low BMI, are primary transplants, have 
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well-matched HLA, and show low Panel Reactive Antigen 
(PRA) titers.(10) In this case, we found two appropriate 
recipient candidates using the above mentioned principles. 
Both recipients were primary transplant patients and 
3-antigen-mismatched in terms of immunologic demand, 
and both patients were female with low BMI. 
  In conclusion, deceased donors with reversible kidney 
damage, even those showing high serum creatinine levels, 
can be acceptable as donors for kidney transplantation if 
the absence of chronic or irreversible renal damage is con-
firmed by pathologic study.
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